Elagolix, an Oral GnRH Antagonist for Endometriosis-Associated Pain: A Randomized Controlled Study.

Bruce CarrLinda GiudiceW Paul DmowskiChris O'BrienPing JiangJoshua BurkeRoland JimenezSteven HassMahesh FuldeoreKristof Chwalisz

Published in: Journal of endometriosis and pelvic pain disorders (2013)

Elagolix effectively reduced endometriosis-associated pelvic pain over a 24-week period and was well-tolerated.

Keyphrases